What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in ...

Inspire Medical Systems’ first quarter showed strong momentum, as results exceeded Wall Street’s expectations for both ...

Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4, ...

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc ...

Inspire Medical Systems, Inc. announced strong financial performance for the fourth quarter and full year of 2024, reporting a 25% increase in revenue for Q4, totaling $239.7 million, and a 28% ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), with a price target of $187.00. Larry Biegelsen has ...

Investment summary. We rate Inspire Medical Systems, Inc. (NYSE:INSP) buy following its Q2 FY22 earnings.With upside in both revenue and the bottom line versus consensus, the stock is well placed ...

Inspire Medical Systems is a rapidly growing medical technology company specializing in a device that treats Obstructive Sleep Apnea. The company is still in the early stages of developing their ...

Inspire Medical's share price has climbed even faster than revenue. Since Inspire Medical's share started trading in May 2018 the total return has been nearly 900%.

Inspire Reports First Profitable Quarter and Year-over-Year Revenue Growth of 76% in the Fourth QuarterMINNEAPOLIS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ...